# Biomarkers in Patients at Risk of Developing Myelodysplastic Syndrome or Other Disorders and in Healthy Participants

> **NCT00899327** · — · UNKNOWN · sponsor: **Oxford University Hospitals NHS Trust** · enrollment: 200 (estimated)

## Conditions studied

- Leukemia
- Myelodysplastic Syndromes

## Interventions

- **GENETIC:** DNA methylation analysis
- **GENETIC:** RNA analysis
- **GENETIC:** cytogenetic analysis
- **GENETIC:** gene expression analysis
- **GENETIC:** mutation analysis
- **GENETIC:** polymerase chain reaction
- **GENETIC:** protein expression analysis
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00899327
- **Lead sponsor:** Oxford University Hospitals NHS Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-01
- **Primary completion:** 2011-12
- **Final completion:** —
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2009-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00899327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00899327, "Biomarkers in Patients at Risk of Developing Myelodysplastic Syndrome or Other Disorders and in Healthy Participants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00899327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*